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background:  Atrial fibrillation (AF) is known to be associated with increased thromboembolism (TE) risk. Implanted cardiac devices are detecting 
brief episodes of AF while available data is conflicting about device-detected AF (DDA) burden associated with higher TE risk
methods:  DDA was defined when AF is detected by: pacemaker, implantable loop recorder, cardiac resynchronization therapy (CRT) or ICD. 
Available literature was reviewed using PubMed, Google Scholar and Clinicaltrials.gov websites regarding DDA burden associated with TE outcomes.
results:  Accumulated data showed a positive association between DDA and TE events with ranged burden from 5 minutes to 24 hours. Advanced 
heart failure (HF) and elevated CHADS2 score lowered the AF burden threshold needed for higher TE risk. TE risk was similar in patients with CHADS2 
of 1 plus AF > 24 hours and patients with CHADS2 of 2 plus AF-burden of 5 minutes. In TRENDS study TE rate was low and resulted in a significant 
power limitation. The ASSERT trial; DDA have a positive correlation with TE (p=0.007) and AF > 6 minutes was a significant predictor of stroke 
(p=0.008). Patients with CRT for advanced systolic HF showed an increased TE risk with AF burden ≥ 3.8 hours / day.
conclusions:  TE risk increased with DDA ≥ 5 minutes in patients with advanced HF or CHADS2 score > 2. Evidence is lacking regarding AF < 5 
minutes / day. Further studies are needed to determine AF-burden threshold among patients with different comorbidities and/or structural heart 
diseases.
 
